Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement
Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement have?
Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement has 78 citations in the OpenAlex counts ScholarIQ stores.
When was Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement published?
Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement has 2016 year in the ScholarIQ index.
What is the open-access status of Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement?
Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement has closed oa status in the ScholarIQ index.
What is the DOI of Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement?
The DOI for Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement is on the source record.
What is the PMID of Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement?
The PMID for Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement is on the source record.
What is the OpenAlex record for Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement?
The OpenAlex for Disruptive Mood Dysregulation Disorder at Ages 13–18: Results from the National Comorbidity Survey—Adolescent Supplement is on the source record.